Literature DB >> 26408538

Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.

Sara Leite1, Sara Rodrigues1, Marta Tavares-Silva2, José Oliveira-Pinto3, Mohamed Alaa4, Mahmoud Abdellatif1, Dulce Fontoura1, Inês Falcão-Pires1, Thierry C Gillebert5, Adelino F Leite-Moreira6, André P Lourenço7.   

Abstract

Myocardial stiffness and upward-shifted end-diastolic pressure-volume (P-V) relationship (EDPVR) are the key to high filling pressures in heart failure with preserved ejection fraction (HFpEF). Nevertheless, many patients may remain asymptomatic unless hemodynamic stress is imposed on the myocardium. Whether delayed relaxation induced by pressure challenge may contribute to high end-diastolic pressure (EDP) remains unsettled. Our aim was to assess the effect of suddenly imposed isovolumic afterload on relaxation and EDP, exploiting a highly controlled P-V experimental evaluation setup in the ZSF1 obese rat (ZSF1 Ob) model of HFpEF. Twenty-week-old ZSF1 Ob (n = 12), healthy Wistar-Kyoto rats (WKY, n = 11), and hypertensive ZSF1 lean control rats (ZSF1 Ln, n = 10) underwent open-thorax left ventricular (LV) P-V hemodynamic evaluation under anesthesia with sevoflurane. EDPVR was obtained by inferior vena cava occlusions to assess LV ED chamber stiffness constant β, and single-beat isovolumic afterload acquisitions were obtained by swift occlusions of the ascending aorta. ZSF1 Ob showed increased ED stiffness, delayed relaxation, as assessed by time constant of isovolumic relaxation (τ), and elevated EDP with normal ejection fraction. Isovolumic afterload increased EDP without concomitant changes in ED volume or heart rate. In isovolumic beats, relaxation was delayed to the extent that time for complete relaxation as predicted by 3.5 × monoexponentially derived τ (τexp) exceeded effective filling time. EDP elevation correlated with reduced time available to relax, which was the only independent predictor of EDP rise in multiple linear regression. Our results suggest that delayed relaxation during pressure challenge is an important contributor to lung congestion and effort intolerance in HFpEF.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  afterload; diastolic function; heart failure with preserved ejection fraction; relaxation

Mesh:

Year:  2015        PMID: 26408538     DOI: 10.1152/ajpheart.00397.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Risk Factors for an Elevated Ventricular End-Diastolic Pressure Prior to the Fontan Operation.

Authors:  Matthew C Schwartz; Michael A Brock; David Nykanen; William DeCampli
Journal:  Pediatr Cardiol       Date:  2017-11-27       Impact factor: 1.655

2.  Global myocardial longitudinal strain in a general population-associations with blood pressure and subclinical heart failure: The Tromsø Study.

Authors:  Michael Stylidis; David A Leon; Assami Rӧsner; Henrik Schirmer
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-18       Impact factor: 2.357

3.  Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.

Authors:  Camilo Toledo; David C Andrade; Claudia Lucero; Alexis Arce-Alvarez; Hugo S Díaz; Valentín Aliaga; Harold D Schultz; Noah J Marcus; Mónica Manríquez; Marcelo Faúndez; Rodrigo Del Rio
Journal:  J Physiol       Date:  2017-03-19       Impact factor: 5.182

4.  Echocardiographic Detection of Increased Ventricular Diastolic Stiffness in Pediatric Heart Transplant Recipients: A Pilot Study.

Authors:  Shahryar M Chowdhury; Ryan J Butts; Anthony M Hlavacek; Carolyn L Taylor; Karen S Chessa; Varsha M Bandisode; Girish S Shirali; Arni Nutting; G Hamilton Baker
Journal:  J Am Soc Echocardiogr       Date:  2017-12-13       Impact factor: 5.251

5.  Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction.

Authors:  Stevan P Tofovic; Eman M Salah; Glenn J Smits; Eric T Whalley; Barry Ticho; Aaron Deykin; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2015-11-19       Impact factor: 4.030

6.  Nicotinamide for the treatment of heart failure with preserved ejection fraction.

Authors:  Mahmoud Abdellatif; Viktoria Trummer-Herbst; Franziska Koser; Sylvère Durand; Rui Adão; Francisco Vasques-Nóvoa; Johanna K Freundt; Julia Voglhuber; Maria-Rosaria Pricolo; Michael Kasa; Clara Türk; Fanny Aprahamian; Elías Herrero-Galán; Sebastian J Hofer; Tobias Pendl; Lavinia Rech; Julia Kargl; Nathaly Anto-Michel; Senka Ljubojevic-Holzer; Julia Schipke; Christina Brandenberger; Martina Auer; Renate Schreiber; Chintan N Koyani; Akos Heinemann; Andreas Zirlik; Albrecht Schmidt; Dirk von Lewinski; Daniel Scherr; Peter P Rainer; Julia von Maltzahn; Christian Mühlfeld; Marcus Krüger; Saša Frank; Frank Madeo; Tobias Eisenberg; Andreas Prokesch; Adelino F Leite-Moreira; André P Lourenço; Jorge Alegre-Cebollada; Stefan Kiechl; Wolfgang A Linke; Guido Kroemer; Simon Sedej
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 19.319

7.  Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.

Authors:  Fang-Fei Wei; Ruicong Xue; Lutgarde Thijs; Weihao Liang; Marvin Owusu-Agyeman; Xin He; Jan A Staessen; Yugang Dong; Chen Liu
Journal:  J Am Heart Assoc       Date:  2020-07-28       Impact factor: 5.501

8.  A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.

Authors:  Pierre E Signore; Guangjie Guo; Zhihua Wei; Weihua Zhang; Al Lin; Ughetta Del Balzo
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.